Picture of Ultimovacs ASA logo

ULTIo Ultimovacs ASA Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Ultimovacs ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Depreciation
Non-Cash Items-63.2-117-152-163-201
Other Non-Cash Items
Changes in Working Capital-1.866.3923.9-6.998.88
Change in Other Assets
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-63-108-126-168-190
Capital Expenditures-0.172-5.28-0.085-0.195-0.025
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.494.553.068.8914.1
Acquisition of Business
Other Investing Cash Flow
Cash from Investing Activities4.32-0.7362.988.6914
Financing Cash Flow Items-25.7-7.3-11.2-0.105-0.38
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3431512603.58-1.85
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash28441.3133-149-159